Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Loading Pathway...

Glutamate receptor 1 Glutamate receptor 2 Glutamate [NMDA] receptor subunit epsilon-1 Glutamate [NMDA] receptor subunit zeta-1 Glutamate [NMDA] receptor subunit epsilon-3 Glutamate [NMDA] receptor subunit epsilon-2 Glutamate [NMDA] receptor subunit epsilon-4 Glutamate [NMDA] receptor subunit 3A Glutamate [NMDA] receptor subunit 3B Sodium channel protein type 10 subunit alpha Sodium channel subunit beta-1 Potassium voltage-gated channel subfamily D member 2 Kv channel- interacting protein 2 Voltage- dependent P/Q-type calcium channel subunit alpha-1A Voltage- dependent L-type calcium channel subunit beta-1 Voltage- dependent calcium channel subunit alpha-2/delta-2 Voltage- dependent T-type calcium channel subunit alpha-1H Voltage- dependent T-type calcium channel subunit alpha-1G Glutamate Ionized Lidocaine K+ K+ Na+ Na+ Ca+ Ca+ Glutamate Na+ Na+ Ca+ Ca+ Ca+ Ca+ Lidocaine Lidocaine Lidocaine H+ Depolarization axon width = 9 Presynaptic Neuron Post-synaptic Neuron Since no action potential arrives to the nerve terminal, calcium entry does not occur and neurotransmitters like glutamate are not released from synaptic vesicles into the synapse. Ionized lidocaine blocks the channel, preventing the entry of sodium into the neuron. Membrane Potential (mV) 0 40 -70 Hyperpolarization Repolarization Peak action potential Resting potential The depolarization phase of the action potential is inhibited, therefore, the action potential cannot be geenrated. ACTION POTENTIAL Time (ms) Lidocaine enters the neuron through diffusion and is ionized with hydrogen. Synpatic Vesicle The post-synaptic neuron is unable to depolarize due to the inhibition of neurotransmitter release. Lidocaine has a variety of administration routes, including intravenous injection, topical jellies and patches, epidurals, opthalmalic, and perineurial.
Mitochondria GRIA1 GRIA2 GRIN2A GRIN1 GRIN2C GRIN2B GRIN2D GRIN3A GRIN3B SCN10A SCN1B KCND2 KCNIP2 CACNA1A CACNB1 CACNA2D2 CACNA1H CACNA1G Glutamate Ionized Lidocaine Potassium Potassium Sodium Sodium Calcium Calcium Glutamate Sodium Sodium Calcium Calcium Calcium Calcium Lidocaine Lidocaine Lidocaine Hydrogen Ion
GRIA1 GRIA2 GRIN2A GRIN1 GRIN2C GRIN2B GRIN2D GRIN3A GRIN3B SCN10A SCN1B KCND2 KCNIP2 CACNA1A CACNB1 CACNA2D2 CACNA1H CACNA1G Gluta Ion Lid K+ K+ Na+ Na+ Ca+ Ca+ Gluta Na+ Na+ Ca+ Ca+ Ca+ Ca+ L-Caine L-Caine L-Caine H+ Depolarization axon width = 9 Presynaptic Neuron Post-synaptic Neuron Since no action potential arrives to the nerve terminal, calcium entry does not occur and neurotransmitters like glutamate are not released from synaptic vesicles into the synapse. Ionized lidocaine blocks the channel, preventing the entry of sodium into the neuron. Membrane Potential (mV) 0 40 -70 Hyperpolarization Repolarization Peak action potential Resting potential The depolarization phase of the action potential is inhibited, therefore, the action potential cannot be geenrated. ACTION POTENTIAL Time (ms) Lidocaine enters the neuron through diffusion and is ionized with hydrogen. Synpatic Vesicle The post-synaptic neuron is unable to depolarize due to the inhibition of neurotransmitter release. Lidocaine has a variety of administration routes, including intravenous injection, topical jellies and patches, epidurals, opthalmalic, and perineurial.
Mitochondria GRIA1 GRIA2 GRIN2A GRIN1 GRIN2C GRIN2B GRIN2D GRIN3A GRIN3B SCN10A SCN1B KCND2 KCNIP2 CACNA1A CACNB1 CACNA2D2 CACNA1H CACNA1G Gluta Ion Lid K+ K+ Na+ Na+ Ca2+ Ca2+ Gluta Na+ Na+ Ca2+ Ca2+ Ca2+ Ca2+ L-Caine L-Caine L-Caine H+